By LabPulse.com staff writers

September 16, 2019 -- Sysmex America is providing a grant to the Clinical Lab 2.0 value-based laboratory initiative to support a multi-institutional demonstration project related to the early detection, intervention, and prevention of anemia.

Clinical Lab 2.0 is backed by the Project Santa Fe Foundation, which was founded in 2016 by Geisinger Health, the Henry Ford Health System, Northwell Health, and TriCore Reference Laboratories. The initiative supports multi-institutional demonstration projects that show the value of lab diagnostics to reduce healthcare costs on a global scale.

Sysmex noted in a statement that it is the first corporate sponsor for Clinical Lab 2.0. Routine complete blood count testing for anemia has potential for early detection of the disease, as well as for reducing complication rates and associated costs, according to the company.

Sysmex releases PS-10 sample preparation system
Sysmex America has begun shipping its PS-10 sample preparation system for flow cytometry applications in the U.S. and Canada.
Sysmex RAS liquid biopsy test headed for Japan
Sysmex Inostics and Merck KGaA's OncoBeam circulating tumor DNA blood test kit for RAS genetic mutations in colorectal cancer is headed for the Japanese...
Sysmex gets CE Mark for XN-31 hematology analyzer
Sysmex has received the CE Mark for its XN-31 automated hematology analyzer, which includes an automated measurement function for red blood cells infected...

Copyright © 2019 LabPulse.com



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email